Skip to main content
Erschienen in: Acta Diabetologica 12/2018

10.10.2018 | Original Article

High prevalence of humoral autoimmunity in first-degree relatives of Mexican type 1 diabetes patients

verfasst von: Norma C. Segovia-Gamboa, Martha E. Rodríguez-Arellano, Andrés Muñoz-Solís, Jorge E. Retana-Jiménez, Germán Vargas-Ayala, Julio Granados, Marisela Jiménez-Sánchez, Carmen Sanchez-Torres

Erschienen in: Acta Diabetologica | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Aims

To assess the prevalence of autoantibodies (Aab) to insulin (IAA), glutamic acid decarboxylase 65 (GADA) and insulinoma antigen 2 (IA-2A), as well as human leukocyte antigen (HLA) class II alleles, in first degree relatives (FDR) of Mexican patients with type 1 diabetes (T1D), and to explore whether these parameters mirror the low incidence of T1D in the Mexican population.

Methods

Aab titers were determined by ELISA in 425 FDR, 234 siblings, 40 offspring and 151 parents of 197 patients with T1D. Typing of HLA-DR and -DQ alleles was performed in 41 Aab-positive FDR using polymerase chain reaction with allele-specific oligotyping.

Results

Seventy FDR (16.47%) tested positive for Aab. The siblings (19.2%) and the offspring (25%) had significantly higher prevalence of Aab than the parents (9.9%). GADA was the most frequent Aab. Almost half of the Aab-positive FDR had two different Aab (45.7%), and none tested positive for three Aab. The highest prevalence of Aab was found among women in the 15–29 years age group. Moreover, the positivity for two Aab was significantly more frequent among females. A considerable number of FDR (48.8%) carried the susceptible HLA-DR3, -DR4, -DQB1*0201 or -DQB1*0302 alleles, but almost none had the high risk genotype HLA-DR3/DR4.

Conclusions

FDR of Mexican T1D patients have high prevalence of islet Aab, comparable to countries with the highest incidence of T1D. However, Aab positivity does not seem to be associated with HLA risk genotypes, which may have an impact on the low incidence of T1D in Mexico.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Eisenbarth GS (1986) Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314:1360–1368CrossRef Eisenbarth GS (1986) Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314:1360–1368CrossRef
2.
Zurück zum Zitat Gale EAM (2002) The rise of childhood type 1 diabetes in the 20th century. Diabetes 51:3353–3361CrossRef Gale EAM (2002) The rise of childhood type 1 diabetes in the 20th century. Diabetes 51:3353–3361CrossRef
3.
Zurück zum Zitat DIAMOND Project Group (2006) Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabet Med 23:857–866CrossRef DIAMOND Project Group (2006) Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabet Med 23:857–866CrossRef
4.
Zurück zum Zitat Foulis AK, McGill M, Farquharson MA (1991)) Insulitis in type 1 (insulin-dependent) diabetes mellitus in man—macrophages, lymphocytes, and interferon-gamma containing cells. J Pathol 165:97–103CrossRef Foulis AK, McGill M, Farquharson MA (1991)) Insulitis in type 1 (insulin-dependent) diabetes mellitus in man—macrophages, lymphocytes, and interferon-gamma containing cells. J Pathol 165:97–103CrossRef
5.
Zurück zum Zitat Ferraro A, Socci C, Stabilini A et al (2011) Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes 60:2903–2913CrossRef Ferraro A, Socci C, Stabilini A et al (2011) Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes 60:2903–2913CrossRef
6.
Zurück zum Zitat Pinkse GG, Tysma OH, Bergen CA, Kester MG, Ossendorp F, van Veelen PA et al (2005) Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc Natl Acad Sci U S A 102:18425–18430CrossRef Pinkse GG, Tysma OH, Bergen CA, Kester MG, Ossendorp F, van Veelen PA et al (2005) Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc Natl Acad Sci U S A 102:18425–18430CrossRef
7.
Zurück zum Zitat Schloot NC, Roep BO, Wegmann D et al (1997) Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Diabetologia 40:564–572CrossRef Schloot NC, Roep BO, Wegmann D et al (1997) Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Diabetologia 40:564–572CrossRef
8.
Zurück zum Zitat Atkinson MA, Kaufman DL, Campbell L, Gibbs KA, Shah SC, Bu DF et al (1992) Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339:458–459CrossRef Atkinson MA, Kaufman DL, Campbell L, Gibbs KA, Shah SC, Bu DF et al (1992) Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339:458–459CrossRef
9.
Zurück zum Zitat Hawkes CJ, Schloot NC, Marks J, Willemen SJ, Drijfhout JW, Mayer EK et al (2000) T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes 49:356–366CrossRef Hawkes CJ, Schloot NC, Marks J, Willemen SJ, Drijfhout JW, Mayer EK et al (2000) T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes 49:356–366CrossRef
10.
Zurück zum Zitat Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464:1293–1300CrossRef Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464:1293–1300CrossRef
11.
Zurück zum Zitat Pociot F, Lernmark A (2016) Genetic risk factors for type 1 diabetes. Lancet 387:2331–2339CrossRef Pociot F, Lernmark A (2016) Genetic risk factors for type 1 diabetes. Lancet 387:2331–2339CrossRef
12.
Zurück zum Zitat Beyerlein A, Donnachie E, Jergens S, Ziegler AG (2016) Infections in early life and development of type 1 diabetes. JAMA 315:1899–1901CrossRef Beyerlein A, Donnachie E, Jergens S, Ziegler AG (2016) Infections in early life and development of type 1 diabetes. JAMA 315:1899–1901CrossRef
13.
Zurück zum Zitat Knip M, Virtanen SM, Akerblom HK (2010) Infant feeding and the risk of type1 diabetes. Am J Clin Nutr 91:1506S–1513SCrossRef Knip M, Virtanen SM, Akerblom HK (2010) Infant feeding and the risk of type1 diabetes. Am J Clin Nutr 91:1506S–1513SCrossRef
14.
Zurück zum Zitat Knip M, Siljander H, Ilonen J, Simell O, Veijola R (2016) Role of humoral beta-cell autoimmunity in type 1 diabetes. Pediatr Diabetes 17:17–24CrossRef Knip M, Siljander H, Ilonen J, Simell O, Veijola R (2016) Role of humoral beta-cell autoimmunity in type 1 diabetes. Pediatr Diabetes 17:17–24CrossRef
15.
Zurück zum Zitat Bingley PJ (2010) Clinical applications of diabetes antibody testing. J Clin Endocrinol Metab 95:25–33CrossRef Bingley PJ (2010) Clinical applications of diabetes antibody testing. J Clin Endocrinol Metab 95:25–33CrossRef
16.
Zurück zum Zitat Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A et al (2013) Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309:2473–2479CrossRef Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A et al (2013) Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309:2473–2479CrossRef
17.
Zurück zum Zitat Bruno G, Maule M, Biggeri A, Ledda A, Mannu C, Merletti F et al (2013) More than 20 years of registration of type 1 diabetes in Sardinian children: temporal variations of incidence with age, period of diagnosis, and year of birth. Diabetes 62:3542–3546CrossRef Bruno G, Maule M, Biggeri A, Ledda A, Mannu C, Merletti F et al (2013) More than 20 years of registration of type 1 diabetes in Sardinian children: temporal variations of incidence with age, period of diagnosis, and year of birth. Diabetes 62:3542–3546CrossRef
18.
Zurück zum Zitat Harjutsalo V, Sund R, Knip M, Groop PH (2013) Incidence of type 1 diabetes in Finland. JAMA 310:427–428CrossRef Harjutsalo V, Sund R, Knip M, Groop PH (2013) Incidence of type 1 diabetes in Finland. JAMA 310:427–428CrossRef
19.
Zurück zum Zitat Joner G, Søvik O (1991) The incidence of type 1 (insulin-dependent) diabetes mellitus 15–29 years in Norway 1978–1982. Diabetologia 34:271–274CrossRef Joner G, Søvik O (1991) The incidence of type 1 (insulin-dependent) diabetes mellitus 15–29 years in Norway 1978–1982. Diabetologia 34:271–274CrossRef
20.
Zurück zum Zitat Kyvik KO, Nystrom L, Gorus F, Songini M, Oestman J, Castell C et al (2004) The epidemiology of type 1 diabetes mellitus is not the same in young adults as in children. Diabetologia 47:377–384CrossRef Kyvik KO, Nystrom L, Gorus F, Songini M, Oestman J, Castell C et al (2004) The epidemiology of type 1 diabetes mellitus is not the same in young adults as in children. Diabetologia 47:377–384CrossRef
21.
Zurück zum Zitat Lawrence JM, Imperatore G, Dabelea D, Mayer-Davis EJ, Linder B, Saydah S et al (2014) Trends in incidence of type 1 diabetes among non-Hispanic white youth in the US, 2002–2009. Diabetes 63:3938–3945CrossRef Lawrence JM, Imperatore G, Dabelea D, Mayer-Davis EJ, Linder B, Saydah S et al (2014) Trends in incidence of type 1 diabetes among non-Hispanic white youth in the US, 2002–2009. Diabetes 63:3938–3945CrossRef
22.
Zurück zum Zitat Diaz-Valencia PA, Bougnères P, Valleron AJ (2015) Global epidemiology of type 1 diabetes in young adults and adults: a systematic review. BMC Public Health 15:255CrossRef Diaz-Valencia PA, Bougnères P, Valleron AJ (2015) Global epidemiology of type 1 diabetes in young adults and adults: a systematic review. BMC Public Health 15:255CrossRef
24.
Zurück zum Zitat Gómez-Díaz RA, Nishimura-Meguro E, Garrido-Magaña E, Lizárraga-Paulin L, Aguilar Herrera BE, Bekker-Méndez C et al (2016) HLA risk haplotype: Insulin deficiency in pediatric type 1 diabetes. Rev Invest Clin 68:128–136PubMed Gómez-Díaz RA, Nishimura-Meguro E, Garrido-Magaña E, Lizárraga-Paulin L, Aguilar Herrera BE, Bekker-Méndez C et al (2016) HLA risk haplotype: Insulin deficiency in pediatric type 1 diabetes. Rev Invest Clin 68:128–136PubMed
25.
Zurück zum Zitat Fourlanos S, Varney MD, Tait BD, Morahan G, Honeyman MC, Colman PG et al (2008) The rising incidence of type 1diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 31:1546–1549CrossRef Fourlanos S, Varney MD, Tait BD, Morahan G, Honeyman MC, Colman PG et al (2008) The rising incidence of type 1diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 31:1546–1549CrossRef
26.
Zurück zum Zitat Gorodezky C, Alaez C, Murguía A, Rodríguez A, Balladares S, Vazquez M et al (2006) HLA and autoimmune diseases: Type 1 diabetes (T1D) as an example. Autoimmun Rev 5:187–194CrossRef Gorodezky C, Alaez C, Murguía A, Rodríguez A, Balladares S, Vazquez M et al (2006) HLA and autoimmune diseases: Type 1 diabetes (T1D) as an example. Autoimmun Rev 5:187–194CrossRef
27.
Zurück zum Zitat Erlich HA, Zeidler A, Chang J, Shaw S, Raffel LJ, Klitz W et al (1993) HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat Genet 3:358–364CrossRef Erlich HA, Zeidler A, Chang J, Shaw S, Raffel LJ, Klitz W et al (1993) HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat Genet 3:358–364CrossRef
28.
Zurück zum Zitat Kukko M, Toivonen A, Kupila A, Korhonen S, Keskinen P, Veijola R et al (2006) Familial clustering of beta-cell autoimmunity in initially non-diabetic children. Diabetes Metab Res Rev 22:53–58CrossRef Kukko M, Toivonen A, Kupila A, Korhonen S, Keskinen P, Veijola R et al (2006) Familial clustering of beta-cell autoimmunity in initially non-diabetic children. Diabetes Metab Res Rev 22:53–58CrossRef
29.
Zurück zum Zitat Incani M, Serafini C, Satta C, Perra L, Scano F, Frongia P et al (2017) High prevalence of diabetes-specific autoimmunity in first-degree relatives of Sardinian patients with type 1 diabetes. Diabetes Metab Res Rev 33:e2864CrossRef Incani M, Serafini C, Satta C, Perra L, Scano F, Frongia P et al (2017) High prevalence of diabetes-specific autoimmunity in first-degree relatives of Sardinian patients with type 1 diabetes. Diabetes Metab Res Rev 33:e2864CrossRef
30.
Zurück zum Zitat Siljander HT, Veijola R, Reunanen A, Virtanen SM, Akerblom HK, Knip M (2007) Prediction of type 1 diabetes among siblings of affected children and in the general population. Diabetologia 50:2272–2275CrossRef Siljander HT, Veijola R, Reunanen A, Virtanen SM, Akerblom HK, Knip M (2007) Prediction of type 1 diabetes among siblings of affected children and in the general population. Diabetologia 50:2272–2275CrossRef
31.
Zurück zum Zitat Yu L, Cuthbertson DD, Eisenbarth GS, Krischer JP (2002) Diabetes Prevention Trial 1: prevalence of GAD and ICA512 (IA-2) autoantibodies by relationship to proband. Ann N Y Acad Sci 958:254–258CrossRef Yu L, Cuthbertson DD, Eisenbarth GS, Krischer JP (2002) Diabetes Prevention Trial 1: prevalence of GAD and ICA512 (IA-2) autoantibodies by relationship to proband. Ann N Y Acad Sci 958:254–258CrossRef
32.
Zurück zum Zitat Ito T, Nakamura K, Umeda E, Kaino Y, Hirai H, Kida K et al (2001) Familial predisposition of type 1 diabetes mellitus in Japan, a country with low incidence. Japan Diabetes Society Data Committee for Childhood Diabetes. J Pediatrics Endocrinol Metab 14:589–595CrossRef Ito T, Nakamura K, Umeda E, Kaino Y, Hirai H, Kida K et al (2001) Familial predisposition of type 1 diabetes mellitus in Japan, a country with low incidence. Japan Diabetes Society Data Committee for Childhood Diabetes. J Pediatrics Endocrinol Metab 14:589–595CrossRef
33.
Zurück zum Zitat Weng J, Zhou Z, Guo L, Zhu D, Ji L, Luo X et al (2018) Incidence of type 1 diabetes in China, 2010-13: population based study. BMJ 360:j5295CrossRef Weng J, Zhou Z, Guo L, Zhu D, Ji L, Luo X et al (2018) Incidence of type 1 diabetes in China, 2010-13: population based study. BMJ 360:j5295CrossRef
34.
Zurück zum Zitat Wang JP, Zhou ZG, Lin J, Huang G, Zhang C, Yang L et al (2007) Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives. Tissue Antigens 70:369–375CrossRef Wang JP, Zhou ZG, Lin J, Huang G, Zhang C, Yang L et al (2007) Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives. Tissue Antigens 70:369–375CrossRef
35.
Zurück zum Zitat Zeidler A, Raffel LJ, Costin G, Shaw SJ, Buchanan TA, Noble J et al (2001) Autoantibodies and human leucocyte antigen class II in first-degree family members of Mexican-American type 1 diabetic patients. J Clin Endocrinol Metab 86:4957–4962CrossRef Zeidler A, Raffel LJ, Costin G, Shaw SJ, Buchanan TA, Noble J et al (2001) Autoantibodies and human leucocyte antigen class II in first-degree family members of Mexican-American type 1 diabetic patients. J Clin Endocrinol Metab 86:4957–4962CrossRef
36.
Zurück zum Zitat Becerril Ángeles M, García Lara SE, González Bárcena D, Ibarra Olmos MA, Torres Ambriz P, Angeles Garay U (2010) Autoantibodies in GAD65 in Mexican adults with diabetes types 1 and 2 and their siblings. Rev Alerg Mex 57:190–195PubMed Becerril Ángeles M, García Lara SE, González Bárcena D, Ibarra Olmos MA, Torres Ambriz P, Angeles Garay U (2010) Autoantibodies in GAD65 in Mexican adults with diabetes types 1 and 2 and their siblings. Rev Alerg Mex 57:190–195PubMed
37.
Zurück zum Zitat Krischer JP, Liu X, Lernmark Å, Hagopian WA, Rewers MJ, She JX et al (2017) The influence of type 1 diabetes genetic susceptibility regions, age, sex, and family history on the progression from multiple autoantibodies to type 1 diabetes: a TEDDY Study Report. Diabetes 66:3122–3129CrossRef Krischer JP, Liu X, Lernmark Å, Hagopian WA, Rewers MJ, She JX et al (2017) The influence of type 1 diabetes genetic susceptibility regions, age, sex, and family history on the progression from multiple autoantibodies to type 1 diabetes: a TEDDY Study Report. Diabetes 66:3122–3129CrossRef
38.
Zurück zum Zitat Tuomilehto J (2013) The emerging global epidemic of type 1 diabetes. Curr Diabetes Rep 13:795–804CrossRef Tuomilehto J (2013) The emerging global epidemic of type 1 diabetes. Curr Diabetes Rep 13:795–804CrossRef
39.
Zurück zum Zitat Songini M, Mannu C, Targhetta C, Bruno G (2017) Type 1 diabetes in Sardinia: facts and hypotheses in the context of worldwide epidemiological data. Acta Diabetol 54:9–17CrossRef Songini M, Mannu C, Targhetta C, Bruno G (2017) Type 1 diabetes in Sardinia: facts and hypotheses in the context of worldwide epidemiological data. Acta Diabetol 54:9–17CrossRef
40.
Zurück zum Zitat Karvonen M, Pitkäniemi M, Pitkäniemi J, Kohtamäki K, Tajima N, Tuomilehto J et al (1997) Sex-difference in the incidence of insulin-dependent diabetes mellitus (IDDM). An analysis of the recent epidemiological data. Diab Metab Rev 13:275–291CrossRef Karvonen M, Pitkäniemi M, Pitkäniemi J, Kohtamäki K, Tajima N, Tuomilehto J et al (1997) Sex-difference in the incidence of insulin-dependent diabetes mellitus (IDDM). An analysis of the recent epidemiological data. Diab Metab Rev 13:275–291CrossRef
41.
Zurück zum Zitat Mrena S, Savola K, Kulmala P, Akerblom HK, Knip M (1999) Staging of preclinical type 1 diabetes in siblings of affected children. Childhood diabetes in Finland Study Group. Pediatrics 104:925–930CrossRef Mrena S, Savola K, Kulmala P, Akerblom HK, Knip M (1999) Staging of preclinical type 1 diabetes in siblings of affected children. Childhood diabetes in Finland Study Group. Pediatrics 104:925–930CrossRef
42.
Zurück zum Zitat Barquera R, Zúñiga J, Hernández-Díaz R, Acuña-Alonzo V, Montoya-Gama K, Moscoso J et al (2008) HLA class I and class II haplotypes in admixed families from several regions of Mexico. Mol Immunol 45:1171–1178CrossRef Barquera R, Zúñiga J, Hernández-Díaz R, Acuña-Alonzo V, Montoya-Gama K, Moscoso J et al (2008) HLA class I and class II haplotypes in admixed families from several regions of Mexico. Mol Immunol 45:1171–1178CrossRef
43.
Zurück zum Zitat Niechciał E, Rogowicz-Frontczak A, Piłaciński S, Fichna M, Skowrońska B, Fichna P et al (2018) Autoantibodies against zinc transporter 8 are related to age and metabolic state in patients with newly diagnosed autoimmune diabetes. Acta Diabetol 55:287–294CrossRef Niechciał E, Rogowicz-Frontczak A, Piłaciński S, Fichna M, Skowrońska B, Fichna P et al (2018) Autoantibodies against zinc transporter 8 are related to age and metabolic state in patients with newly diagnosed autoimmune diabetes. Acta Diabetol 55:287–294CrossRef
44.
Zurück zum Zitat Rodríguez-Ventura AL, Yamamoto-Furusho JK, Coyote N, Dorantes LM, Ruiz-Morales JA, Vargas-Alarcón G et al (2007) HLA-DRB1*08 allele may help to distinguish between type 1 diabetes mellitus and type 2 diabetes mellitus in Mexican children. Pediatr Diabetes 8:5–10CrossRef Rodríguez-Ventura AL, Yamamoto-Furusho JK, Coyote N, Dorantes LM, Ruiz-Morales JA, Vargas-Alarcón G et al (2007) HLA-DRB1*08 allele may help to distinguish between type 1 diabetes mellitus and type 2 diabetes mellitus in Mexican children. Pediatr Diabetes 8:5–10CrossRef
Metadaten
Titel
High prevalence of humoral autoimmunity in first-degree relatives of Mexican type 1 diabetes patients
verfasst von
Norma C. Segovia-Gamboa
Martha E. Rodríguez-Arellano
Andrés Muñoz-Solís
Jorge E. Retana-Jiménez
Germán Vargas-Ayala
Julio Granados
Marisela Jiménez-Sánchez
Carmen Sanchez-Torres
Publikationsdatum
10.10.2018
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 12/2018
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1241-9

Weitere Artikel der Ausgabe 12/2018

Acta Diabetologica 12/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.